LIGAND PHARMACEUTICALS INCORPORATED Interest Expense Nonoperating
LIGAND PHARMACEUTICALS INCORPORATED (LGND) reported Interest Expense Nonoperating of $1.75 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-07
- LIGAND PHARMACEUTICALS INCORPORATED interest expense nonoperating for the quarter ending 2026-06-30 was $1.75M, a 51.60% increase year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED interest expense nonoperating for the quarter ending 2026-03-31 was $1.75M, a 101.50% increase year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED interest expense nonoperating for the quarter ending 2025-12-31 was $1.78M, a 102.15% increase year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED interest expense nonoperating for the quarter ending 2025-09-30 was $910.00K, a 22.81% increase year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED interest expense nonoperating for fiscal 2025 was $4.71M, a 55.25% increase from fiscal 2024.
- LIGAND PHARMACEUTICALS INCORPORATED interest expense nonoperating for fiscal 2024 was $3.04M, a 362.96% increase from fiscal 2023.
- LIGAND PHARMACEUTICALS INCORPORATED interest expense nonoperating for fiscal 2023 was $656.00K, a 63.54% decline from fiscal 2022.
- LIGAND PHARMACEUTICALS INCORPORATED interest expense nonoperating for fiscal 2022 was $1.80M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.75M 10-Q · filed 2026-08-07 | $3.50M 10-Q · filed 2026-08-07 | $5.28M derived: sum of 3 quarters · filed 2026-08-07 | $6.19M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $1.75M 10-Q · filed 2026-05-08 | $3.53M derived: sum of 2 quarters · filed 2026-05-08 | $4.44M derived: sum of 3 quarters · filed 2026-05-08 | $5.59M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $2.69M derived: sum of 2 quarters · filed 2026-02-27 | $3.85M derived: sum of 3 quarters · filed 2026-08-07 | $4.71M 10-K · filed 2026-02-27 |
| 2025-09-30 | $910.00K 10-Q · filed 2025-11-07 | $2.06M derived: sum of 2 quarters · filed 2026-08-07 | $2.93M 10-Q · filed 2025-11-07 | $3.81M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $1.15M 10-Q · filed 2026-08-07 | $2.02M 10-Q · filed 2026-08-07 | $2.90M derived: sum of 3 quarters · filed 2026-08-07 | $3.64M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $867.00K 10-Q · filed 2026-05-08 | $1.75M derived: sum of 2 quarters · filed 2026-05-08 | $2.49M derived: sum of 3 quarters · filed 2026-05-08 | $3.76M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $883.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $1.62M derived: sum of 2 quarters · filed 2026-02-27 | $2.89M derived: sum of 3 quarters · filed 2026-02-27 | $3.04M 10-K · filed 2026-02-27 |
| 2024-09-30 | $741.00K 10-Q · filed 2025-11-07 | $2.01M derived: sum of 2 quarters · filed 2025-11-07 | $2.15M 10-Q · filed 2025-11-07 | $2.28M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $1.27M 10-Q · filed 2025-08-08 | $1.41M 10-Q · filed 2025-08-08 | $1.54M derived: sum of 3 quarters · filed 2026-02-27 | $1.54M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $141.00K 10-Q · filed 2025-05-09 | $272.00K derived: sum of 2 quarters · filed 2026-02-27 | $273.00K derived: sum of 3 quarters · filed 2026-02-27 | $557.00K derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $131.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $132.00K derived: sum of 2 quarters · filed 2026-02-27 | $416.00K derived: sum of 3 quarters · filed 2026-02-27 | $656.00K 10-K · filed 2026-02-27 |
| 2023-09-30 | $1.00K 10-Q · filed 2024-11-08 | $285.00K derived: sum of 2 quarters · filed 2024-11-08 | $525.00K 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $284.00K 10-Q · filed 2024-08-07 | $524.00K 10-Q · filed 2024-08-07 | ||
| 2022-12-31 | $1.80M 10-K · filed 2025-02-28 |